Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

IQVBullishCorporate Developmentsnews

High materiality8/10

IQVIA expands Veeva collaboration to standardize core trial software suite

Oct 13, 2026, 7:11 AM EDT1 sourcesAI-analyzed

Why it may matterVerify against the original reporting

Strategic deepening of an existing technology partnership can raise IQVIA's software-related revenue visibility, improve client retention, and broaden long-cycle contract value through upsell and cross-sell of Veeva-enabled solutions.

AI summary

What happened, with direct paths to the underlying reporting

IQVIA and Veeva expanded their collaboration, naming CTMS, eTMF, Study Startup, and Site Connect as enterprise standards across IQVIA clinical development. The move builds on the existing EDC partnership, potentially increasing sponsor adoption of the Veeva stack via IQVIA and expanding recurring revenue while improving trial speed and site-centric operations.

IQVIA expands partnership with Veeva; CTMS, eTMF, Study Startup, Site Connect standard across IQVIA studies.
Extends prior EDC partnership; broadens integration and potential Veeva stack upsell.
Aims to speed trials, boost site-centricity, and accelerate patient access.
IQVIA emphasizes flexible tech choices including EDC, RTSM and eCOA.
Veeva summit Oct 20-21 in Boston to learn more.

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.